Robert G. Fish, M.D.

  1. Family Physician
  1. Kuzu MA, Benlice C, Parvaiz A, Gorgun E, Bertelsen CA, Wexner S, Dozois EJ, Hohenberger W, Miskovic D, Sugihara K, Spinelli A, Wiggers T, Lee WY, Moslein G, Tsarkov P, Basany EE, Patron Uriburu JC, Perez RO, Lynch C, Liu Z, Hahnloser D, Nilsson PJ, Chowdri NA, Brown G, Rouanet P, Madoff RD, West NP, Sahin T, Elhan AH, Bordeianou LG, Colon Cancer Delphi Consensus Study Group. Standardizing the Definition of Each Colon Cancer Segment: Delphi Consensus on Clinical Decision-Making for Oncologic Outcomes. Dis Colon Rectum. 2025 Jul 1; 68 (7):835-844 Epub 2025 Apr 11
    View PubMed
  2. Pimienta AL, Billings TA, Fish RG. Paraneoplastic Phenomena in a Patient With Locally Destructive and Metastatic Renal Cell Carcinoma. J Prim Care Community Health. 2018 Jan-Dec; 9:2150132718799023
    View PubMed
  3. Garrison GM, Traverse CR, Fish RG. A Case Study of Visit-Driven Preventive Care Screening Using Clinical Decision Support: The Need to Redesign Preventive Care Screening. Health Serv Res Manag Epidemiol. 2016 Jan-Dec; 3:2333392816650344 Epub 2016 June 16
    View PubMed
  4. Lincoff AM, Tardif JC, Schwartz GG, Nicholls SJ, Ryden L, Neal B, Malmberg K, Wedel H, Buse JB, Henry RR, Weichert A, Cannata R, Svensson A, Volz D, Grobbee DE. Effect of aleglitazar on cardiovascular outcomes after acute coronary syndrome in patients with type 2 diabetes mellitus: the AleCardio randomized clinical trial. JAMA. 2014 Apr 16; 311 (15):1515-25
    View PubMed